Zevra Therapeutics

ZVRA · NASDAQ

$10.47+$0.31 (+3.05%)TodayMarket closed ·
Prev close $10.16

Who owns ZVRA

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 43.3% of ZVRA’s shares.

  • Woodline Partners LP8.1%
  • Fidelity Management & Research Company LLC8.0%
  • BlackRock Institutional Trust Company, N.A.7.9%
  • Vanguard Capital Management, LLC4.5%
  • Next 6 largest institutions14.8%
  • All other shareholders56.7%
Top institutional holders of ZVRA
HolderShares% of shares
Woodline Partners LP4.79M8.10%
Fidelity Management & Research Company LLC4.72M7.98%
BlackRock Institutional Trust Company, N.A.4.68M7.91%
Vanguard Capital Management, LLC2.64M4.46%
Nantahala Capital Management, LLC1.80M3.04%
State Street Investment Management (US)1.68M2.85%
Geode Capital Management, L.L.C.1.54M2.61%
D. E. Shaw & Co., L.P.1.31M2.21%
Qube Research & Technologies Ltd1.24M2.10%
Legal & General Investment Management Ltd.1.20M2.03%

Largest mutual fund holders

Top mutual fund holders of ZVRA
HolderShares% of shares
Fidelity Contrafund2.94M4.97%
Vanguard Total Stock Market Index Fund1.90M3.21%
iShares Russell 2000 ETF1.52M2.57%
Vanguard Extended Market Index Fund680.93K1.15%
Janus Henderson Small/Mid Cap Growth Alpha ETF677.46K1.15%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $1.30M (5 trades) of ZVRA on the open market, with no buys.

Latest ZVRA insider transactions
InsiderTypeSharesValue
McFarlane Neil F.Sale20.00K$224.95K
McFarlane Neil F.Option exercise50.00K—
McFarlane Neil F.Option exercise50.00K—
Thompson RahsaanSale42.67K$474.77K
Watton Corey MichaelOption exercise12.30K—
Watton Corey MichaelSale12.30K$138.38K
Watton Corey MichaelOption exercise12.30K$61.13K
Thompson RahsaanSale34.56K$438.30K
Thompson RahsaanOption exercise66.67K—
Thompson RahsaanOption exercise66.67K—

Short interest

Settled Sep 30, 2026

Shares short
7.15M
Days to cover
7.16
% of shares outstanding
12.09%
Average daily volume
998.16K
Change since last report
+24.5%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.